Border to Coast Pensions Partnership Ltd Buys 23,123 Shares of Danaher Co. (NYSE:DHR)

Border to Coast Pensions Partnership Ltd grew its stake in shares of Danaher Co. (NYSE:DHR) by 13.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 199,150 shares of the conglomerate’s stock after acquiring an additional 23,123 shares during the period. Border to Coast Pensions Partnership Ltd’s holdings in Danaher were worth $45,684,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Coronation Fund Managers Ltd. raised its holdings in shares of Danaher by 29.9% in the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares in the last quarter. Moors & Cabot Inc. increased its holdings in Danaher by 14.0% during the second quarter. Moors & Cabot Inc. now owns 2,540 shares of the conglomerate’s stock valued at $635,000 after buying an additional 311 shares during the period. Primecap Management Co. CA raised its stake in Danaher by 3.4% in the second quarter. Primecap Management Co. CA now owns 66,937 shares of the conglomerate’s stock worth $16,724,000 after buying an additional 2,200 shares in the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in Danaher by 31.8% during the second quarter. Mercer Global Advisors Inc. ADV now owns 56,282 shares of the conglomerate’s stock worth $14,062,000 after buying an additional 13,576 shares during the period. Finally, Waterloo Capital L.P. boosted its position in Danaher by 9.9% during the 2nd quarter. Waterloo Capital L.P. now owns 5,618 shares of the conglomerate’s stock valued at $1,404,000 after acquiring an additional 506 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.7 %

Danaher stock opened at $241.94 on Friday. Danaher Co. has a 52 week low of $222.53 and a 52 week high of $281.70. The stock has a 50-day moving average price of $235.07 and a 200 day moving average price of $253.45. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $174.75 billion, a price-to-earnings ratio of 46.17, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the firm earned $2.02 EPS. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. Sell-side analysts anticipate that Danaher Co. will post 7.49 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s payout ratio is currently 20.61%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on DHR shares. KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Citigroup cut their price objective on shares of Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays decreased their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Finally, Scotiabank started coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $286.80.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.